The value of DCE-MRI in assessing histopathological and molecular biological features in induced rat epithelial ovarian carcinomas

The value of DCE-MRI in assessing histopathological and molecular biological features in induced rat epithelial ovarian carcinomas

Abstract Background To investigate dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) for assessing histopathological and molecular biological features in induced rat epithelial ovarian carcinomas (EOCs). Methods 7,12-dimethylbenz[A]anthracene (DMBA) was applied to induce EOCs in situ in...

Full description

Bibliographic Details
Main Authors:	Su Juan Yuan, Tian Kui Qiao, Jin Wei Qiang, Song Qi Cai, Ruo Kun Li
Format:	Article
Language:	English
Published:	BMC 2017-09-01
Series:	Journal of Ovarian Research
Subjects:	Epithelial ovarian carcinoma (EOC) Dynamic contrast-enhanced magnetic resonance imaging Microvessel density Vascular endothelial growth factor Cancer antigen 125
Online Access:	http://link.springer.com/article/10.1186/s13048-017-0362-z

Similar Items

Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers
by: Vikneswary Ravi Kumar, et al.
Published: (2023-11-01)

Epithelial Ovarian Cancer—Varied Treatment Results
by: Sonja Millert-Kalińska, et al.
Published: (2023-07-01)

RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer
by: Xuedong Wang, et al.
Published: (2023-11-01)

CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
by: Sipei Nie, et al.
Published: (2021-09-01)

High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer
by: Liwei Zhang, et al.
Published: (2022-02-01)

FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers via the MAPK/ERK Pathway
by: Minle Li, et al.
Published: (2021-12-01)

Assessment of carcinoembryonic antigen as a prognostic marker in ovarian malignancies treated in a rural hospital of West Bengal
by: Phalguni Chakrabarti, et al.
Published: (2022-05-01)

CA-125 and Ceruloplasmin Levels in Ovarian Cancer Patients
by: Mangala Hegde, et al.
Published: (2015-09-01)

The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer
by: Chao-Lien Liu, et al.
Published: (2021-07-01)

The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer
by: Mark W. Nachtigal, et al.
Published: (2022-07-01)

Diffusion-weighted imaging and diffusion kurtosis imaging for early evaluation of the response to docetaxel in rat epithelial ovarian cancer
by: Su-juan Yuan, et al.
Published: (2018-12-01)

GPR12 Inhibits Apoptosis in Epithelial Ovarian Cancer via the Activation of ERK1/2 Signaling
by: Lu Wang, et al.
Published: (2022-07-01)

Comparison of semi-quantitative and quantitative dynamic contrast-enhanced MRI evaluations of vertebral marrow perfusion in a rat osteoporosis model
by: Jingqi Zhu, et al.
Published: (2017-11-01)

Analysis of Role of Angiogenesis in Epithelial Dysplasia: An Immunohistochemical Study
by: Sonia Gupta, et al.
Published: (2017-12-01)

Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis
by: Martín Salamini-Montemurri, et al.
Published: (2023-06-01)

"CAN PREOPERATIVE CA-125 PREDICT RESECTABILITY OF TUMOR IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CARCINOMA?"
by: M. Modarres-Gilani, et al.
Published: (2004-12-01)

"CAN PREOPERATIVE CA-125 PREDICT RESECTABILITY OF TUMOR IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CARCINOMA?"
by: M. Modarres-Gilani, et al.
Published: (2004-11-01)

A Double-Negative Feedback Interaction between MicroRNA-29b and DNMT3A/3B Contributes to Ovarian Cancer Progression
by: Yue Teng, et al.
Published: (2016-11-01)

MiR-596 activated by EP300 controls the tumorigenesis in epithelial ovarian cancer by declining BRD4 and KPNA4
by: Deying Wang, et al.
Published: (2020-09-01)

Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer
by: Jing He, et al.
Published: (2019-11-01)

Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker
by: Juan Fernando Sánchez Vega, et al.
Published: (2018-05-01)

Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment
by: Yan Xu
Published: (2018-07-01)

Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors
by: Ke Huang, et al.
Published: (2023-02-01)

Exosome Component 4 Promotes Epithelial Ovarian Cancer Cell Proliferation, Migration, and Invasion via the Wnt Pathway
by: Chang Xiong, et al.
Published: (2021-12-01)

Prognostic Significance of Log(CA125)/PCI for the Resectability of Epithelial Ovarian Cancer: A Retrospective Study
by: He C, et al.
Published: (2020-03-01)

Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
by: Ji Hui Choi, et al.
Published: (2018-05-01)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
by: G. N. A. Winarno, et al.
Published: (2020-07-01)

Prognostic performance of pretreatment systemic immune-inflammation index in women with epithelial ovarian cancer
by: Kehinde S Okunade, et al.
Published: (2023-12-01)

Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125
by: Szu-Ting Yang, et al.
Published: (2023-11-01)

AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer Patients
by: Po-Chao Hsu, et al.
Published: (2021-09-01)

Role of Thrombopoietin in the Diagnosis of Ovarian Cancer: A Brief Review
by: Amar Ranjan, et al.
Published: (2018-04-01)

Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
by: Masaya Uno, et al.
Published: (2023-07-01)

Comparing the Diagnostic Value of the Risk of Ovarian Malignancy Algorithm and CA125 in Patients with Ovarian Mass
by: Alireza Rezaee, et al.
Published: (2019-07-01)

HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial
by: Michel Fabbro, et al.
Published: (2024-01-01)

The Effect of Delayed Chemotherapy on the Decrease of CA125 in Epithelial Ovarian Cancer During Coronavirus Disease Pandemic in 2020
by: Yi Q, et al.
Published: (2021-01-01)

Is Ovarian Mass Malignancy Prediction Accuracy Increased by Adding Serum CA125 Measurement to Sonographic Findings?
by: Maliheh Arab, et al.
Published: (2012-03-01)

Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints
by: Delphine Hudry, et al.
Published: (2022-10-01)

Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer
by: Zhongmian Pan, et al.
Published: (2023-02-01)

Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer
by: Xueqing Yang, et al.
Published: (2020-08-01)

Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation
by: Lan Dai, et al.
Published: (2021-05-01)